In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oncternal Therapeutics Inc.

www.oncternal.com

Latest From Oncternal Therapeutics Inc.

Start-Up Quarterly Statistics: Anthos, Gossamer Lead Q1 Financings; Codiak/Jazz Deal Tops Alliances

In a review of biopharma start-up dealmaking and financing activity from January through March, based on data from Strategic Transactions, Anthos completed the largest venture capital round in the first quarter, raising $250m.

Deals Financing

Deal Watch: Oncternal Goes Public Via Reverse Merger With GTx

All-stock transaction combines privately held Oncternal with GTx, which had been considering its strategic alternatives. Biogen acquires gene therapy biotech Nightstar, MaxCyte and Kite expand their CAR-T partnership.

Deals Business Strategies

Venture Funding Deals

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced in January and February 2017.

Commercial StartUps and SMEs

Start-Up Quarterly Statistics, Q2 2016

A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.

Financing Deals
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Oncternal Therapeutics Inc.
  • Senior Management
  • James Breitmeyer, MD, PhD, Pres. & CEO
    Richard Vincent, CFO
    Lauren Otsuki, COO
    Gunnar Kaufmann, PhD, CSO
    Igor Bilinsky, PhD, Chief Bus. Officer
  • Contact Info
  • Oncternal Therapeutics Inc.
    Phone: (858) 434-1113
    3525 Del Mar Heights Rd.
    #821
    San Diego, CA 92130
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register